Urologic Oncology Fellowship in Department of Urology
University of Michigan
As a surgeon-scientist, Dr. Palapattu maintains equal footing in the lab and clinic. The long term goal of his research program is to improve the outcomes of men with prostate cancer. Dr. Palapattu’s research seeks to shed new light on human prostate cancer stem cells, the prostate tumor microenvironment, mechanisms of prostate cancer progression, the biologic basis of prostate cancer health disparity, prostate cancer metabolism and improved methods of intra-operative prostate cancer and cavernous nerve imaging to aid surgical resection. His laboratory work has received funding from the National Cancer Institute (NCI), the Department of Defense, the Prostate Cancer Foundation and the New York Academy of Sciences, among others. From a clinical perspective, Dr. Palapattu’s practice centers on i) prostate cancer, particularly high-risk disease, employing robotic prostatectomy and nerve-sparing techniques and ii) kidney cancer, from partial to radical nephrectomy with caval thrombectomy utilizing robotic, laparoscopic and open approaches.